Proteins and peptides now constitute a major proportion of therapeutic modalities being pursued for the treatment of various diseases 1. Nearly 30% of all drugs approved by the US Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . Hormone therapy skin patches containing low-dose estrogen appear to carry less risk for stroke than oral therapy ...
A review in the Annals of Pharmacotherapy examined the literature on alternative routes of administration for antipsychotic and antidepressant medications via inhaled, intranasal, buccal, sublingual, ...
Findings demonstrate for the first time that the impact of oral estrogen extends beyond effects on circulating IGF-I levels as GH-induced stimulation of fat oxidation, protein metabolism also affected ...
The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report deals with transdermal drug ...
Please provide your email address to receive an email when new articles are posted on . Risk for venous thromboembolism does not differ for women using oral conjugated equine estrogen vs. oral or ...
Objective: To summarize the pharmaceutics, pharmacokinetics, development, and clinical application of IONSYS, the fentanyl HCl patient-controlled iontophoretic transdermal system for the management of ...
The MarketWatch News Department was not involved in the creation of this content. SUMMIT, N.J., Dec. 3, 2025 /PRNewswire/ -- Vascarta Inc., is pleased to share results from a new study led by ...
The global transdermal drug delivery systems market size was US$ 55100.33 million in 2021. The global transdermal drug delivery systems market size is forecast to reach US$ 88,422.40 million by 2030, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback